Zagit Gaymalov, Ph.D.

Co-founder & CEO
NeuroNano Pharma

Dr. Zagit Gaymalov is co-founder and chief executive officer of NeuroNano Pharma, a biopharmaceutical company developing novel nanotherapeutics for the treatment of obesity and Alzheimer disease. In addition, he also serves as a deputy director for translational research at the University of North Carolina at Chapel Hill, The Center for Nanotechnology in Drug Delivery. Dr. Gaymalov’s professional focus is on the advancement of paths to commercialization for academia derived innovative healthcare technologies, products, and services. Dr. Gaymalov also serves as the president of Pharma Leads, a healthcare marketing consultancy, helping its clients with innovations’ commercialization in pharma and biotech industries.

Dr. Gaymalov received his Ph.D. in Pharmaceutical Sciences from the College of Pharmacy at the University of Nebraska Medical Center. He did his graduate work on the delivery of macromolecules and development of cancer immunotherapies, under the patronage of world-renowned leader in drug delivery and nanomedicine, Dr. Alexander V. Kabanov.